miR-141-3p下调溶血磷脂酸受体3抑制脑胶质瘤细胞增殖、迁移和上皮-间质转化

doi:10.16352/j.issn.1001-6325.2025.12.1580

基础医学与临床 ›› 2025, Vol. 45 ›› Issue (12): 1580-1587.doi: 10.16352/j.issn.1001-6325.2025.12.1580

miR-141-3p下调溶血磷脂酸受体3抑制脑胶质瘤细胞增殖、迁移和上皮-间质转化

李文辉¹, 任红岗¹, 郭剑¹, 宋洋¹, 冯富强^2*

1.临汾市人民医院神经外科,山西临汾 041000;
2.山西省肿瘤医院中国医学科学院肿瘤医院山西医院山西医科大学附属肿瘤医院神经外科,山西太原 030013

收稿日期:2025-01-16 修回日期:2025-03-25 出版日期:2025-12-05 发布日期:2025-11-25
通讯作者: ^*doctorfengfuqiang@163.com
基金资助:
山西省基础研究计划(20210302123265);山西省卫生健康委科研课题(2021060)

miR-141-3p down-regulating lysophosphatidic acid receptor3 inhibits proliferation, migration and epithelial-mesenchymal transition of brain glioma cells

LI Wenhui¹, REN Honggang¹, GUO Jian¹, SONG Yang¹, FENG Fuqiang^2*

1. Department of Neurosurgery, Linfen People′s Hospital, Linfen 041000;
2. Department of Neurosurgery, Shanxi Cancer Hospital, Chinese Academy of Medical Sciences Cancer Hospital Shanxi Hospital, the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan 030013, China

Received:2025-01-16 Revised:2025-03-25 Online:2025-12-05 Published:2025-11-25
Contact: ^*doctorfengfuqiang@163.com

摘要/Abstract

摘要： 目的探讨miR-141-3p调控溶血磷脂酸受体3(LPAR3)对脑胶质瘤细胞增殖、迁移和上皮细胞-间质转化的影响。方法 RT-qPCR检测脑胶质瘤组织及细胞中miR-141-3p、LPAR3 mRNA水平;双荧光素酶检测miR-141-3p与LPAR3的靶向关系;将细胞分为control组、miR-NC组、miR-141-3p mimics组、miR-141-3p mimics+pcDNA3.1组、miR-141-3p mimics+pcDNA-LPAR3组,分别转染相应质粒24 h;RT-qPCR检测细胞中miR-141-3p、LPAR3 mRNA水平;EdU检测细胞增殖;划痕愈合实验检测细胞迁移;Western blot检测细胞增殖、迁移和上皮细胞-间质转化相关蛋白表达;裸鼠移植瘤实验观察瘤形成情况,RT-qPCR检测瘤组织miR-141-3p水平,Western blot检测LPAR3、PCNA、MMP-2表达。结果在脑胶质瘤组织及U251、T98G、CHG-5细胞中miR-141-3p水平降低,LPAR3 mRNA水平升高(P＜0.05);miR-141-3p与LPAR3之间存在靶向结合位点;miR-141-3p mimics可升高miR-141-3p水平及E-cadherin表达,降低LPAR3 mRNA水平、EdU阳性率、划痕愈合率、PCNA、cyclin D1、MMP-2、MMP-9、N-cadherin、vimentin表达(P＜0.05);pcDNA-LPAR3可逆转上述因子表达趋势(P＜0.05);裸鼠移植瘤实验显示,miR-141-3p mimics可降低瘤体积、瘤重及LPAR3、PCNA、MMP-2表达,升高miR-141-3p水平(P＜0.05)。结论 miR-141-3p可通过下调LPAR3抑制脑胶质瘤细胞增殖、迁移、上皮细胞-间质转化。

关键词: miR-141-3p, 溶血磷脂酸受体3, 脑胶质瘤细胞, 增殖, 上皮-间质转化

Abstract: Objective To investigate the impacts of miR-141-3p on the proliferation, migration and epithelial-mesenchymal transformation of glioma cells by regulating lysophosphatidic acid receptor 3 (LPAR3). Methods RT-qPCR was used to detect the level of miR-141-3p and LPAR3 in glioma tissues and cells. Dual luciferase was used to detect the targeting relationship between miR-141-3p and LPAR3. The cells were divided into control group, miR-NC group, miR-141-3p mimics group, miR-141-3p mimics+pcDNA3.1 group, and miR-141-3p mimics+pcDNA-LPAR3 group, and then transfected with corresponding plasmids. RT-qPCR was used to detect the level of miR-141-3p and LPAR3 in cells. EdU method was used to detect cell proliferation. The scratch healing experiment was used to detect cell migration. Western blot was used to detect the expression of proteins related to cell proliferation, migration, and epithelial-mesenchymal transformation. Xenograft tumor model in nude mice was used to observe tumor formation. RT-qPCR was used to detect the level of miR-141-3p in tumor tissue. In addition, Western blot was performed to detect the expression of LPAR3, PCNA, and MMP-2. Results miR-141-3p was downregulated, whereas LPAR3 mRNA was upregulated in glioma tissues and U251, T98G, and CHG-5 cell lines (P＜0.05). There was a targeted binding site between miR-141-3p and LPAR3. miR-141-3p mimics significantly increased the expression of miR-141-3p and E-cadherin, but decreased LPAR3 mRNA level, EdU-positive rate, scratch wound healing rate, and the expression of PCNA, cyclin D1, MMP-2, MMP-9, N-cadherin, and vimentin (P＜0.05). pcDNA-LPAR3 reversed effect on expression of these factors (P＜0.05). Tumor transplantation experiments in nude mice showed that miR-141-3p mimics reduced tumor volume, tumor weight, LPAR3, PCNA, and MMP-2 expression, and increased the level of miR-141-3p (P＜0.05). Conclusions miR-141-3p can inhibit proliferation, migration, and epithelial-mesenchymal transformation of glioma cells by down-regulating LPAR3.

Key words: miR-141-3p, lysophosphatidic acid receptor 3, glioma cell, proliferation, epithelial-mesenchymal transformation

中图分类号:

R739.41

李文辉, 任红岗, 郭剑, 宋洋, 冯富强. miR-141-3p下调溶血磷脂酸受体3抑制脑胶质瘤细胞增殖、迁移和上皮-间质转化[J]. 基础医学与临床, 2025, 45(12): 1580-1587.

LI Wenhui, REN Honggang, GUO Jian, SONG Yang, FENG Fuqiang. miR-141-3p down-regulating lysophosphatidic acid receptor3 inhibits proliferation, migration and epithelial-mesenchymal transition of brain glioma cells[J]. Basic & Clinical Medicine, 2025, 45(12): 1580-1587.

参考文献 15

[1]	Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review[J]. JAMA, 2023, 329:574-587.
[2]	Wang Z, Li J, Yuan Y, et al. Prognostic significance of preoperative systemic inflammation response index in newly diagnosed glioblastoma patients underwent gross total resection: a propensity score matching analysis[J]. World J Surg Oncol, 2022, 20:137-147.
[3]	Bassot A, Dragic H, Haddad SA, et al. Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma[J]. Cell Death Dis, 2023, 14:630-645.
[4]	Yu M, Yi B, Zhou W, et al. Linc00475 promotes the progression of glioma by regulating the miR-141-3p/YAP1 axis[J]. J Cell Mol Med, 2021, 25:463-472.
[5]	Doutt SW, Longo JF, Carroll SL. LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells[J]. Glia, 2023, 71:742-757.
[6]	Jiménez-Morales JM, Hernández-Cuenca YE, Reyes-Abrahantes A, et al. MicroRNA delivery systems in glioma therapy and perspectives: a systematic review[J]. J Control Release, 2022, 349:712-730.
[7]	Bilski M, Ciesielka M, Orzechowska M, et al. miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomas[J]. Sci Rep, 2024, 14:29345-29357.
[8]	江源铭, 盛宝英. miR-141-3p对脑胶质瘤细胞生长和Wnt信号通路的影响[J]. 安徽医科大学学报, 2019, 54:1562-1565.
[9]	Benesch MGK, Wu R, Tang X, et al. Lysophosphatidic acid receptor signaling in the human breast cancer tumor microenvironment elicits receptor-dependent effects on tumor progression[J]. Int J Mol Sci, 2023, 24:9812-9830.
[10]	Hirata N, Yamada S, Yanagida S, et al. Lysophos-phatidic acid promotes the expansion of cancer stem cells via trpc3 channels in triple-negative breast cancer[J]. Int J Mol Sci, 2022, 23:1967-1984.
[11]	马丽英, 马新福, 马春兰. miR-15b靶向LPAR3对食管癌细胞增殖、迁移及侵袭的影响[J]. 临床与实验病理学杂志, 2022, 38:727-730.
[12]	Yin D, Kong C, Chen M. Effect of hnRNPA2/B1 on the proliferation and apoptosis of glioma U251 cells via the regulation of AKT and STAT3 pathways[J]. Biosci Rep, 2020, 40:1-11.
[13]	Zuo J, Liu C, Ni H, et al. WDR34 affects PI3K/Akt and Wnt/β-catenin pathways to regulates malignant biological behaviors of glioma cells[J]. J Neurooncol, 2022, 156:281-293.
[14]	Song Y, Li C, Jin L, et al. RIOK2 is negatively regulated by miR-4744 and promotes glioma cell migration/invasion through epithelial-mesenchymal transition[J]. J Cell Mol Med, 2020, 24:4494-4509.
[15]	Su RY, Hsueh SC, Chen CY, et al. Demethoxycurcumin suppresses proliferation, migration, and invasion of human brain glioblastoma multiforme gbm 8401 cells via pi3k/akt pathway[J]. Anticancer Res, 2021, 41:1859-1870.

miR-141-3p下调溶血磷脂酸受体3抑制脑胶质瘤细胞增殖、迁移和上皮-间质转化

miR-141-3p down-regulating lysophosphatidic acid receptor3 inhibits proliferation, migration and epithelial-mesenchymal transition of brain glioma cells

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 15

相关文章 15

编辑推荐

Metrics

本文评价

[1]	程志坚, 王国毓, 贺西京, 翟静静, 王涛宁. 小鼠骨髓来源巨噬细胞原代培养中NG2表达及生物活性[J]. 基础医学与临床, 2026, 46(1): 1-4.
[2]	韦新闻, 温小军, 樊钊强, 劳锡峰, 张鲁青, 钟鸣. CircAPLP2通过调节miR-455-3p/STMN1轴抑制人结直肠癌细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2025, 45(9): 1208-1214.
[3]	安信, 贾麟, 马吾苏木·马木特, 黄志鹏, 卡哈尔曼·斯拉木, 热夏提·热合曼, 海日拉·吾拉木, 库尔班江·阿布力克木, 加素尔·巴吐尔. ANGPT1影响小鼠前列腺癌细胞系RM-1增殖、侵袭及血管生成[J]. 基础医学与临床, 2025, 45(9): 1165-1172.
[4]	邹庆波, 张国臣, 潘长景. 绞股蓝皂苷抑制人前列腺癌细胞系PC-3增殖、迁移和侵袭[J]. 基础医学与临床, 2025, 45(8): 1059-1065.
[5]	赵翠娟, 敖民, 武文博, 李妍华. 高脂饮食加重小鼠肠易激综合征肠屏障损伤[J]. 基础医学与临床, 2025, 45(8): 1022-1027.
[6]	田野, 何权, 王小娟. RPRD1B在人卵巢癌细胞系中高表达并促进肿瘤细胞增殖[J]. 基础医学与临床, 2025, 45(8): 1066-1072.
[7]	殷利军, 卜阳, 昂格勒玛, 宋琳琳. LncRNA HIF1A-AS1通过干预HIF1A促进胃癌细胞系增殖[J]. 基础医学与临床, 2025, 45(5): 627-636.
[8]	魏建新, 房彦乐, 鲁雨博, 高宇光, 郎兴, 李静涛, 马新生. 青蒿琥酯抑制肾母细胞瘤细胞系SK-NEP-1增殖和促进凋亡与自噬[J]. 基础医学与临床, 2025, 45(4): 493-498.
[9]	周晶, 屈苗. 上调miR-152抑制ox-LDL诱导的人血管平滑肌细胞增殖和迁移[J]. 基础医学与临床, 2025, 45(4): 486-492.
[10]	张瑶, 张璇, 贾安娜, 战世佳, 郭金鑫, 常艳, 郭永丽. 嗅素结构域家族蛋白3促进MYCN扩增型神经母细胞瘤细胞系体外增殖[J]. 基础医学与临床, 2025, 45(2): 168-175.
[11]	郭书焕, 高亚丽, 陈静鸽. miR-132-3p通过靶向调控SIRT1/NF-κB通路影响滋养层细胞上皮-间质转化[J]. 基础医学与临床, 2025, 45(12): 1565-1571.
[12]	韩伟, 潘伟, 张曼, 高翔宇, 康心凯, 朱志博, 刘瑞廷. 滨蒿内酯抑制结肠癌细胞系HCT116的增殖和侵袭[J]. 基础医学与临床, 2025, 45(11): 1429-1437.
[13]	杜红蕾, 张锋, 郭海彦, 徐宁, 吴震. 大车前苷抑制人胃癌细胞系BGC823增殖和侵袭[J]. 基础医学与临床, 2025, 45(10): 1333-1340.
[14]	申红梅, 于燕, 冯绪强, 王克强. 松萝酸抑制人卵巢癌细胞系增殖[J]. 基础医学与临床, 2025, 45(1): 31-37.
[15]	肖艳红, 姜明东, 林叶远, 冉灿, 梁博. 灯盏花乙素抑制人前列腺癌细胞系PC-3的增殖和迁移[J]. 基础医学与临床, 2024, 44(9): 1229-1235.